CV Sciences Non-GAAP EPS of -$0.01, revenue of $3.75M

• CV Sciences press release (OTCQB:CVSI): Q3 Non-GAAP EPS of -$0.01.
• Revenue of $3.75M (-26.6% Y/Y).
• Gross margin of 41.6% for third quarter of 2022, compared to 46.2% for the third quarter of 2021.
• Total cash balance of $1.1M at quarter end, compared to $1.4M at year end.
• The company had negative adjusted EBITDA for the third quarter of 2022 of $1.2M, compared to negative adjusted EBITDA of $2.7M in the third quarter of 2021.